HIF-1 was first identified as a transcription factor regulating EPO in human hepatoma cells, while in vivo hypoxic stimulation of EPO and erythropoiesis is primarily mediated by HIF-2 [67–69]. Here, EPO is linked to hepatocellular carcinoma.